Chemotherapy is usually the next step — sending potent drugs into the body, either orally or through an IV, to kill cancer cells.
But chemo can also damage healthy cells. So researchers are looking at a new approach called targeted therapy — drugs that kill cancer cells but minimize damage to normal cells. Research is still in the testing phase, and the FDA has not yet approved a targeted therapy drug to treat ovarian cancer.
